(NYSE: AVNS) Avanos Medical's forecast annual revenue growth rate of 0.76% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.56%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.43%.
Avanos Medical's revenue in 2025 is $687,800,000.On average, 2 Wall Street analysts forecast AVNS's revenue for 2025 to be $31,160,693,684, with the lowest AVNS revenue forecast at $31,052,126,250, and the highest AVNS revenue forecast at $31,269,261,118. On average, 2 Wall Street analysts forecast AVNS's revenue for 2026 to be $32,094,557,629, with the lowest AVNS revenue forecast at $32,077,996,495, and the highest AVNS revenue forecast at $32,111,118,763.
In 2027, AVNS is forecast to generate $33,119,277,795 in revenue, with the lowest revenue forecast at $33,116,287,591 and the highest revenue forecast at $33,122,268,000.